(Total Views: 230)
Posted On: 02/10/2019 1:36:22 PM
Post# of 149807
Mono phase 3 is going on for over one year , patients on 700 mg for over 4 months , all together in phase 3 probably about 400 patients .
Close to 700 patients for many years without one serious side effect.
At the end if efficacy will be not 92 but little lower , like 85 , this will still be excellent.
But in the last interview Feb 7 , Dr NP said at about 17:35 minute ... that during maintenance phase of induction/maintenance therapy , efficacy was over 90%
Some patients on monotherapy for over 4 years , no resistance so far.
Some patients with failure but there was a good explanation , more dens CCR5 needed higher doses , also with flu , vaccination etc.
With this history very little can go wrong.
IMO.
Close to 700 patients for many years without one serious side effect.
At the end if efficacy will be not 92 but little lower , like 85 , this will still be excellent.
But in the last interview Feb 7 , Dr NP said at about 17:35 minute ... that during maintenance phase of induction/maintenance therapy , efficacy was over 90%
Some patients on monotherapy for over 4 years , no resistance so far.
Some patients with failure but there was a good explanation , more dens CCR5 needed higher doses , also with flu , vaccination etc.
With this history very little can go wrong.
IMO.
(1)
(0)Scroll down for more posts ▼
